Navigation Links
Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years
Date:1/3/2012

NEW YORK, Jan. 3, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years

http://www.reportlinker.com/p0747902/Private-Equity-and-Venture-Capital-PE/VC-Activity-in-Medical-Devices---Number-of-Investments-in-Smaller-Companies-has-Increased-over-the-Past-Four-Years.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices

Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years

Summary

GBI Research's report, "Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years" provides key data, information and analysis on the global medical devices market. The report provides private equity and venture capital (PE/VC) activity in 18 medical device market categories – In Vitro Diagnostics, Cardiovascular Devices, Orthopedic Devices, Anesthesia and Respiratory Devices, Dental Devices, Diabetes Care devices, Diagnostic Imaging, Drug Delivery Devices, Endoscopy Devices, Ear, Nose and Throat Devices, Healthcare IT, Hospital Supplies, Nephrology and Urology, Neurology Devices, Ophthalmic Devices, Patient Monitoring, Surgical Equipment and Wound Care Management. The report provides comprehensive information on the factors affecting PE/VC investment in these categories. The report also reviews the detailed analysis of the PE/VC deals worth greater than $100m in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

- Key geographies covered include North America, Europe and the Asia-Pacific.

- PE/VC activity in the following market categories – In Vitro Diagnostics, Cardiovascular Devices, Orthopedic Devices, Anesthesia and Respiratory Devices, Dental Devices, Diabetes Care devices, Diagnostic Imaging, Drug Delivery Devices, Endoscopy Devices, ENT Devices, Healthcare IT, Hospital Supplies, Nephrology and Urology, Neurology Devices, Ophthalmic Devices, Patient Monitoring, Surgical Equipment and Wound Care Management

- PE/VC deals from 2007 to 2010 in the medical device market and detailed analysis of deals greater than $100m in size.

- The report also covers top financial advisors for the PE/VC deals from 2007 to 2010 in the medical device market.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the medical devices market globally.

- Design and develop your product development, marketing and sales strategies.

- Exploit PE/VC opportunities by identifying market players with the most innovative pipeline.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.

- What's the next big thing in the PE/VC activity in medical devices landscape? Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global medical devices market and the factors shaping it.

Table of Contents

1 Table of Contents

1 Table of Contents 4

1.1 List of Tables 7

1.2 List of Figures 8

2 Introduction 9

2.1 GBI Research Report Guidance 9

3 PE/VC Deals Summary in the Medical Device Industry 10

3.1 PE/VC Deals by Number and Deal Value, 2007–2010 10

3.2 Segmentation of PE/VC Deals by Stages, 2007–2010 11

3.2.1 Conclusion 12

3.3 Withdrawn/Terminated Deals 12

3.3.1 Ion Beam Applications Terminated Sale of Its BioAssays Unit 13

3.3.2 Smiths Group Rejects Cash Bid of Apax Partners for Smiths Medical 13

3.3.3 Ares Life Sciences, Essex, Intesa and Alpha Terminated Acquisition of Sorin 14

3.3.4 AMICAS Terminated Acquisition with Thoma Bravo 14

3.3.5 Q-Med Terminated Offer for Its Acquisition by Ivytan 15

3.3.6 Endologix Terminated Offer for Its Acquisition by Elliot Associates 15

3.3.7 Conclusion 16

4 PE/VC Deals in Medical Devices by Geography 17

4.1 PE/VC Deals in North America 17

4.2 PE/VC Deals in Europe 19

4.3 PE/VC Deals in the Asia-Pacific 21

4.3.1 Conclusion 22

5 PE/VC Activity in Medical Devices by Market 23

5.1 In Vitro Diagnostics 23

5.1.1 Deals Analysis 24

5.1.2 PE/VC Deals - In Vitro Diagnostics 24

5.1.3 Pacific Biosciences Secured Additional $59m in Series F Round of Financing 25

5.1.4 Legal & General Ventures Sells LGC to Bridgepoint 25

5.1.5 Welsh, Carson, Anderson & Stowe Acquired Spectrum Laboratory Network from Apax Partners 26

5.1.6 Bridgepoint Capital Acquired Terveystalo Healthcare 27

5.1.7 Duke Street Acquired Biomnis 27

5.1.8 The EQT V fund Acquired Dako Denmark 28

5.2 Cardiovascular Devices 29

5.2.1 Deal Analysis 30

5.2.2 Ares Life Sciences Acquired Stake in Esaote 30

5.2.3 Boston Scientific Sells Fluid Management and Venous Access Businesses To Avista Capital 31

5.2.4 Cardionet Secures $110m in Series E Financing 32

5.3 Orthopedic Devices 33

5.3.1 Deals Analysis 34

5.3.2 Small Bone Innovations Secured $108m in Series D Financing 36

5.3.3 Globus Medical Secures $110m Series E Financing 36

5.4 Anesthesia and Respiratory Devices 38

5.4.1 Deals Analysis 39

5.4.2 Water Street Healthcare Acquires Stake in CareCentrix from Gentiva Health 39

5.5 Dental Devices 40

5.5.1 Deals Analysis 41

5.5.2 TA Associates Acquired Stake in Amann Girrbach 41

5.5.3 Palamon Capital Partners Completes Acquisition of Associated Dental Partners 42

5.6 Diabetes Care Devices 43

5.6.1 Deals Analysis 44

5.6.2 The Blackstone Group Acquires Apria Healthcare 44

5.7 Diagnostic Imaging 45

5.7.1 Deals Analysis 46

5.7.2 Bridgepoint Capital Acquired Terveystalo Healthcare 46

5.7.3 Merrill Lynch and Ares Acquires Euromedic from Warburg Pincus 47

5.7.4 Avista Capital Partners Acquired Bristol-Myers Squibb Medical Imaging 48

5.7.5 Dubai International Capital Acquired Alliance Medical from Bridgepoint Capital 48

5.7.6 DeA Capital and Mediobanca Acquired 53% Majority Stake in Generale de Sante 49

5.8 Drug Delivery Devices 50

5.8.1 Deals Analysis 51

5.8.2 Warburg Pincus Acquired Lifecore Biomedical 51

5.9 Endoscopy Devices 52

5.9.1 Deals Analysis 53

5.9.2 TPG Capital Acquires Axcan Pharma 53

5.10 Ear, Nose and Throat (ENT) Devices 54

5.10.1 Deals Analysis 55

5.10.2 Technitrol Sells Medtech Component Business To Altor 55

5.11 Healthcare IT 56

5.11.1 Huntsman Gay Global Acquires 51% Stake in Sunquest Information from Vista Equity Partners 58

5.11.2 BC Partners and Silver Lake Acquires MultiPlan from the Carlyle Group and Welsh, Carson, Anderson & Stowe 58

5.11.3 OMERS Private Equity Completes Acquisition of Logibec Groupe Informatique 59

5.11.4 Francisco Partners Completes Acquisition Of Quadramed 60

5.11.5 ikaSystems Received Additional Investment From Essex Woodlands Health 61

5.11.6 Truveris Raises $3.8m in First Venture Financing Round 61

5.11.7 Glocal Healthcare Systems to Raise $3.25m in Venture Financing 62

5.11.8 Apax Partners, Bluecross Blueshield and Regence Group Acquired the TriZetto Group 62

5.11.9 Merrill Lynch and Ares Acquired Euromedic From Warburg Pincus 63

5.11.10 General Atlantic And Hellman & Friedman Acquires Remaining 48% Stake In Emdeon Business Services From HLTH 64

5.11.11 TA Associates Acquired Alere Medical 64

5.12 Hospital Supplies 66

5.12.1 Deals Analysis 67

5.12.2 The Blackstone Group Completes Acquisition of Polymer Group 67

5.12.3 EQT Partners Completed Acquisition of HTL-Strefa 68

5.12.4 Lehman Brothers Acquired Angelica 68

5.12.5 Tenet Healthcare Sells Its Majority Stake in Broadlane to TowerBrook Capital Partners 69

5.13 Nephrology and Urology Devices 70

5.13.1 Deals Analysis 71

5.13.2 Merrill Lynch and Ares Acquired Euromedic from Warburg Pincus 71

5.14 Neurology Devices 72

5.14.1 Deals Analysis 73

5.15 Ophthalmic Devices 73

5.15.1 3i Acquired Ultralase from Corporacion Dermoestetica 74

5.15.2 Warburg Pincus Acquired Bausch & Lomb 75

5.16 Patient Monitoring 76

5.16.1 Deals Analysis 77

5.16.2 TA Associates Acquired Alere Medical 77

5.17 Surgical Equipment 78

5.17.1 Deals Analysis 79

5.17.2 PerkinElmer Sells Illumination and Detection Solutions Business to Veritas Capital Fund Management 79

5.17.3 HLTH Sells Porex to Aurora Capital 80

5.18 Wound Care Management 81

5.18.2 Investor Acquired 34% Stake in Molnlycke Health Care 82

5.18.3 Nordic Capital Fund and Avista Capital Partners Acquire ConvaTec from Bristol-Myers Squibb 83

5.18.4 Investor and Morgan Stanley Completed Acquisition of Molnlycke Health Care from Apax Partners 84

6 Global Medical Devices, Top Financial Advisors 86

6.1 Top Financial Advisors, PE/VC Deals Medical Devices 86

7 PE/VC Activity in Medical Devices- Appendix 87

7.1 Acronyms 87

7.2 Research Methodology 88

7.2.1 Secondary Research 88

7.2.2 Primary Research 88

7.2.3 Models 89

7.2.4 Forecasts 89

7.2.5 Expert Panels 89

7.3 Contact Us 89

7.4 Disclaimer 90

7.5 Sources 90

List of Tables

1.1 List of Tables

Table 1: Medical Devices Market, Global, PE/VC, by Number of Deals and Deal Value, 2007-2010 10

Table 2: Medical Devices Industry, Global, PE/VC Deals, Number of Deals by Stages, 2007-2010 11

Table 3: Medical Devices Industry, Global, PE/VC Deals, Withdrawn/Terminated Deals, 2007–2010 12

Table 4: Medical Devices Industry, North America, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007–2010 17

Table 5: Medical Devices, Europe, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007–2010 19

Table 6: Medical Devices Industry, Asia-Pacific, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007–2010 21

Table 7: In Vitro Diagnostics Market, Global, PE/VC, by Number of Deals, 2007–2010 23

Table 8: In Vitro Diagnostics Market, Global, PE/VC, by Deal Value ($m), 2007–2010 23

Table 9: In Vitro Diagnostics, Global, PE/VC Deals, 2007–2010 24

Table 10: Cardiovascular Devices Market, Global, PE/VCs, by Number of Deals, 2007–2010 29

Table 11: Cardiovascular Devices Market, Global, PE/VCs, by Deal Value ($m), 2007–2010 29

Table 12: Cardiovascular Devices, Global, PE/VC, 2007-2010 30

Table 13: Orthopedic Devices Market, Global, PE/VC, by Number of Deals, 2007–2010 33

Table 14: Orthopedic Devices Market, Global, PE/VC, by Deal Value ($m), 2007–2010 33

Table 15: Orthopedics Devices Market, Global, PE/VC, 2007–2010 35

Table 16: Anesthesia and Respiratory Devices Market, Global, PE/VC, by Number of Deals, 2007–2010 38

Table 17: Anesthesia and Respiratory Devices Market, Global, PE/VC, by Deal Value ($m), 2007–2010 38

Table 18: Anesthesia and Respiratory Devices Market, Global, PE/VC, by Volume, 2007–2010 39

Table 19: Dental Devices Market, Global, PE/VC, by Number of Deals, 2007–2010 40

Table 20: Dental Devices Market, Global, PE/VC, by Deal Value ($m), 2007–2010 40

Table 21: Dental Devices Market, Global, PE/VC, 2007–2010 41

Table 22: Diabetes Care Devices Market, Global, PE/VC, by Number of Deals, 2007–2010 43

Table 23: Diabetes Care Devices Market, Global, PE/VC, by Deal Value ($m), 2007–2010 43

Table 24: Diabetes Care Devices, Global, PE/VC, 2007–2010 44

Table 25: Diagnostic Imaging Market, Global, PE/VC, by Number of Deals, 2007–2010 45

Table 26: Diagnostic Imaging Market, Global, PE/VC, by Deal Value ($m), 2007–2010 45

Table 27: Diagnostic Imaging Market, Global, PE/VC, by Deal Value ($m), 2007–2010 46

Table 28: Drug Delivery Devices Market, Global, PE/VC, by Number of Deals, 2007–2010 50

Table 29: Drug Delivery Devices Market, Global, PE/VC, by Deal Value ($m), 2007–2010 50

Table 30: Drug Delivery Devices, Global, PE/VC, 2007–2010 51

Table 31: Endoscopy Devices Market, Global, PE/VC, by Number of Deals, 2007–2010 52

Table 32: Endoscopy Devices Market, Global, PE/VC, by Deal Value ($m), 2007–2010 52

Table 33: Endoscopy Devices Market, PE/VC, by Volume, Global, 2007–2010 53

Table 34: ENT Devices Market, Global, PE/VC, by Number of Deals, 2007–2010 54

Table 35: ENT Devices Market, PE/VC, by Deal Value ($m), Global, 2007–2010 54

Table 36: ENT Devices Market, Global, PE/VC, by Deal Volume, 2007–2010 55

Table 37: Healthcare IT Market, Global, PE/VC, by Number of Deals, 2007–2010 56

Table 38: Healthcare IT Market, Global, PE/VC, by Deal Value ($m), 2007–2010 56

Table 39: Healthcare IT Market, Global, PE/VC, by Deal Volume, 2007-2010 57

Table 40: Hospital Supplies Market, Global, PE/VC, by Number of Deals, 2007–2010 66

Table 41: Hospital Supplies Market, Global, PE/VC, by Deal Value ($m), 2007–2010 66

Table 42: Hospital Supplies Market, Global, PE/VC, by Deal Volume, 2007–2010 67

Table 43: Nephrology and Urology Devices Market, Global, PE/VC, by Number of Deals, 2007–2010 70

Table 44: Nephrology and Urology Devices Market, Global, PE/VC, by Deal Value ($m), 2007–2010 70

Table 45: Nephrology and Urology Devices Market, Global, PE/VC, by Deal Volume, 2007–2010 71

Table 46: Neurology Devices Market, Global, PE/VC, by Number of Deals, 2007–2010 72

Table 47: Neurology Devices Market, Global, PE/VC, by Deal Value ($m), 2007–2010 72

Table 48: Ophthalmic Devices Market, Global, PE/VC, by Number of Deals, 2007–2010 73

Table 49: Ophthalmic Devices Market, Global, PE/VC, by Deal Value ($m), 2007–2010 74

Table 50: Ophthalmic Devices Market, Global, PE/VC, by Deal Volume 2007-2010 74

Table 51: Patient Monitoring Devices Market, Global, PE/VC, by Number of Deals, 2007–2010 76

Table 52: Patient Monitoring Devices Market, Global, PE/VC, by Deal Value ($m), 2007–2010 76

Table 53: Patient Monitoring Devices Market, Global, PE/VC, by Deal Volume, 2007–2010 77

Table 54: Surgical Equipment Market, Global, PE/VC, by Number of Deals, 2007–2010 78

Table 55: Surgical Equipment Market, Global, PE/VC, Deal Value ($m), 2007–2010 78

Table 56: Surgical Equipment Market, Global, PE/VC, 2007–2010 79

Table 57: Wound Care Management Market, Global, PE/VC, by Number of Deals, 2007–2010 81

Table 58: Wound Care Management Market, Global, PE/VC, by Deal Value ($m), 2007–2010 81

Table 59: Wound Care Management, Global, PE/VC Deals, 2007–2010 82

Table 60: Medical Devices, Top Legal Advisors, 2007–2010 86

List of Figures

1.2 List of Figures

Figure 1: Medical Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 10

Figure 2: Medical Devices Industry, Global, PE/VC Deals, Deals by Stages (%), 2007–2010 11

Figure 3: Medical Devices Industry, North America, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007–2010 17

Figure 4: Medical Devices Industry, Europe, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007–2010 19

Figure 5: Medical Devices Industry, Asia-Pacific, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007–2010 21

Figure 6: In Vitro Diagnostics Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 23

Figure 7: Cardiovascular Devices Market, Global, PE/VCs, by Number of Deals and Deal Value ($m), 2007–2010 29

Figure 8: Orthopedic Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 33

Figure 9: Orthopedic Devices, Global, Pipeline Products Summary, 2010 34

Figure 10: Anesthesia and Respiratory Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 38

Figure 11: Dental Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 40

Figure 12: Diabetes Care Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 43

Figure 13: Diagnostic Imaging Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 45

Figure 14: Drug Delivery Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 50

Figure 15: Endoscopy Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 52

Figure 16: ENT Devices Market, PE/VC, Global, by Number of Deals and Deal Value ($m), 2007–2010 54

Figure 17: Healthcare IT Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 56

Figure 18: Hospital Supplies Market, PE/VC, Global, by Number of Deals and Deal Value ($m), 2007–2010 66

Figure 19: Nephrology and Urology Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 70

Figure 20: Neurology Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 72

Figure 21: Ophthalmic Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 73

Figure 22: Patient Monitoring Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 76

Figure 23: Surgical Equipment Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 78

Figure 24: Wound Care Management Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007–2010 81

Figure 25: Medical Devices, Global, PE/VC Deals, Top Financial Advisors, 2007–2010 86

Companies Mentioned

To order this report:

Medical Devices Industry: Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years

More  Market Research Report

Check our  Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections
2. NeuroVasx, Inc. Announces $8.5 Million Private Placement and Completion of cPAX Aneurysm Treatment Study
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
5. Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
6. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
7. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
8. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
9. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
10. Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
11. World Heart Corp. Completes $7.3 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... Research and Markets has ... Myeloid Leukemia Market and Competitive Landscape Highlights ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Competitive Landscape Highlights 2016, provides comprehensive insights ... Myeloid Leukemia epidemiology, Acute Myeloid Leukemia market ...
(Date:5/3/2016)... 2016 Global Insulin Needles ... 09 key companies and supported with 272 tables ... study on the current state of the Insulin ... industry including definitions, classifications, applications and industry chain ... for the international market including development history, competitive ...
(Date:5/3/2016)... , May 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product ... Photo - http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... ... Seminars for Business Journalists , led by the Wharton School’s most prominent ... issues.  This one-day program at the Wharton School’s San Francisco campus will ...
(Date:5/5/2016)... Cambridge, MA (PRWEB) , ... May 05, 2016 ... ... distinctions among workers’ compensation laws in all U.S. states and certain Canadian provinces ... (IAIABC) and the Workers Compensation Research Institute (WCRI). , The report, ...
(Date:5/5/2016)... ... May 05, 2016 , ... Tim Dieter has ... families of greater Dubuque, IA. The current campaign fundraises for Veteran’s Freedom Center ... Donations to Veteran’s Freedom Center may now be made here: http://www.veteransfreedomcenter.com/donate/ . ...
(Date:5/5/2016)... ... May 05, 2016 , ... Dr. Benjamin Stong of Kalos Facial Plastic ... Dr. Stong is double board certified and the only facial plastic surgeon in ... hair loss. Non-surgical therapies such as stem cells can be used to provide stabilization ...
(Date:5/5/2016)... ... (PRWEB) May 05, 2016 , ... Talent Tech Labs ... on the eve of National Nurses Week (May 6-12). Currently, HireNurses is ... With their enrollment into the Talent Tech Lab Virtual Incubation program, they will dramatically ...
Breaking Medicine News(10 mins):